Schroder Investment Management Group Ultragenyx Pharmaceutical Inc. Transaction History
Schroder Investment Management Group
- $101 Billion
- Q4 2024
A detailed history of Schroder Investment Management Group transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 376,161 shares of RARE stock, worth $16 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
376,161
Previous 182,865
105.7%
Holding current value
$16 Million
Previous $10.2 Million
55.79%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
86.6MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$427 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$239 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$183 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$116 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$107 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.98B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...